From 1 May 2021 passengers traveling to Singapore will be able use IATA Travel Pass to present their pre departure PCR test results at Changi Airport.
Developed by IATA, the Travel Pass is a personal secure digital wallet solution that can be used by passengers to retrieve and store COVID-19 test results from accredited laboratories.
“Having the confidence of an aviation leader like Singapore accept IATA Travel Pass is hugely significant. Ongoing trials put us on track for IATA Travel Pass to be a critical tool for the industry’s restart by delivering verified travel health credentials to governments. And travelers can have complete confidence that their personal data is secure and under their own control. The success of our joint efforts will make IATA’s partnership with the government of Singapore a model for others to follow,” said Willie Walsh, IATA’s Director General.
Following successful trials by Singapore Airlines, Singapore health and border control authorities will adopt the IATA Travel Pass as a valid form of presentation of COVID-19 pre-departure test results for entry into Singapore.
More than 20 airlines have recently announced that they are trying out the IATA Travel Pass.
